1. < Home

Primary Graft Dysfunction

Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement

Greenland JR, Perch M, Halloran K, Levine DJ, Morrell ED, Reed A, Shaver CM, Singer JP, Sweet SC, Vos R, Aryal S, Avdimiretz N, Burrows[...]

By afschroeder • December 17, 2025
Long-term outcomes of the international EXPAND trial of Organ Care System (OCS) Lung preservation for lung transplantation

Loor G, Warnecke G, Villavicencio MA, Smith MA, Zhou X, Kukreja J, Ardehali A, Hartwig MG, Daneshmand MA, Hertz MI, Huddleston SJ, Haverich A, Madsen[...]

By afschroeder • July 22, 2025
Severe primary graft dysfunction in heart transplant recipients using donor hearts after circulatory death: United States experience

Cho PD, Kim ST, Zappacosta H, White JP, McKay S, Biniwale R, Ardehali A. Severe primary graft dysfunction in heart transplant recipients using donor hearts[...]

By sjmartinez • April 14, 2025
A randomized trial of open lung protective ventilation compared to conventional mechanical ventilation in deceased organ donors

Ware LB, Koyama T, Shaver CM, Swain S, Nguyen J, Salehi A, Dhillon G, Wickersham N, Maheshwari J, Singer JP, Weigt SS, Kukreja J, Matthay[...]

By sjmartinez • April 6, 2025
Alterations in Circulating Measures of Th2 Immune Responses Pre-Lung Transplant Associates with Reduced Primary Graft Dysfunction

Schaenman J, Weigt SS, Pan M, Lee JJ, Zhou X, Elashoff D, Shino M, Reynolds JM, Budev M, Shah P, Singer LG, Todd JL, Snyder[...]

By sjmartinez • July 21, 2024